rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

David Tsao

Chief Technology Officer

Company insider

Files Form 4 as: Chief Technology Officer, BillionToOne.

In numbers

Trades disclosed
118
Buys
1
Sells
7
Bought
$60K
Sold
$19.9M
Companies
1
Companies where not an officer
0
First trade
7 Nov 2025
Last trade
5 Oct 2026
Last filed
7 Oct 2026

Companies traded

Where they are an officer
BLLN BillionToOneDirector, Officer · Diagnostics & Labs · last 5 Oct 20261 buy · 7 sells

Activity over time

1 Nov 2025 – 1 Oct 2026
201Nov 25Feb 26May 26Jul 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code M$28K10,000 at $2.80filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$236K2,200 at $107.47filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$534K4,916 at $108.53filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$200K1,829 at $109.14filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$11K100 at $110.09filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$28K10,000 at $2.80filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$28K10,000 at $2.80filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code M$28K10,000 at $2.80filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$92K866 at $105.90filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$205K1,909 at $107.20filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$464K4,284 at $108.39filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$318K2,921 at $109.00filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$2,20220 at $110.08filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$59K555 at $105.56filing
5 Oct 2026filed 7 Oct 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$42K400 at $106.10filing
24 Sep 2026filed 28 Sep 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code M$9,3323,333 at $2.80filing
24 Sep 2026filed 28 Sep 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Sold$417K3,333 at $125.00filing
24 Sep 2026filed 28 Sep 2026BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$9,3323,333 at $2.80filing
24 Sep 2026filed 28 Sep 2026BLLN BillionToOneoption or derivative · Diagnostics & LabsSEC FORM 4 Code M$9,3323,333 at $2.80filing
24 Sep 2026filed 28 Sep 2026BLLN BillionToOneDiagnostics & LabsSEC FORM 4 Code M$9,3323,333 at $2.80filing

Sectors

Health Care8

Buys in green, sells in red, by the company’s sector.

Related people

Thomas P. LynchOfficer · Officer at BillionToOne, filing Form 4 there in the last year
Oguzhan AtayChairman and CEO · Chairman and CEO at BillionToOne, filing Form 4 there in the last year
John Roderick ten BoschSVP of Laboratory Operations · SVP of Laboratory Operations at BillionToOne, filing Form 4 there in the last year
Shan Riku SakakibaraChief Product Officer · Chief Product Officer at BillionToOne, filing Form 4 there in the last year
Krishna Kittu KolluriDirector · Director at BillionToOne, filing Form 4 there in the last year